AMSTERDAM – About two-thirds of children with JIA remained in remission after 5 years when a 3-month course of the IL-1 receptor antagonist...
The approval, the first for a marijuana-derived pharmaceutical product, falls in line with the unanimous recommendation of an FDA advisory panel...
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...
LOS ANGELES – Could results help to guide decisions on immunosuppressive treatment?
LOS ANGELES – Survey aimed to describe the wide variation in their off-label use, particularly in infants.